PubRank

F J Monsma

Author PubWeight™ 59.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990 8.07
2 Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995 5.74
3 Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 1994 2.27
4 Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001 2.26
5 Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992 2.13
6 Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 1993 1.84
7 Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci U S A 1997 1.62
8 Cloning and expression of an A1 adenosine receptor from rat brain. Mol Pharmacol 1991 1.51
9 ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 2000 1.42
10 Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 1995 1.40
11 Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci U S A 1990 1.27
12 Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001 1.26
13 Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. Endocrinology 1983 1.13
14 The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res 1996 1.12
15 Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 1993 1.11
16 Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci U S A 1996 1.11
17 Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 1996 1.08
18 Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. Mol Pharmacol 1998 1.05
19 Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 1996 1.04
20 High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor. J Med Chem 2000 1.00
21 Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J Biol Chem 1998 0.98
22 Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. J Pharmacol Exp Ther 1995 0.96
23 Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol 1991 0.96
24 Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J Biol Chem 2000 0.96
25 Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol 2000 0.94
26 Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem 1996 0.93
27 Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. Mol Pharmacol 1997 0.93
28 Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells. Neuropharmacology 1997 0.91
29 Expression of dopamine D1A receptor gene in proximal tubule of rat kidneys. Am J Physiol 1993 0.91
30 Synthesis and processing of D2 dopamine receptors. Biochemistry 1993 0.91
31 Organ specificity of the dopamine1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am J Physiol 1993 0.91
32 Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen. Endocrinology 1984 0.89
33 Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands. Proc Natl Acad Sci U S A 1989 0.88
34 Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity. Brain Res 1991 0.87
35 Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity. Biochemistry 1987 0.86
36 Characterization of the 5' flanking region of the human D1A dopamine receptor gene. Proc Natl Acad Sci U S A 1992 0.83
37 Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor. J Neurochem 1998 0.82
38 Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells. Mol Pharmacol 1993 0.81
39 Molecular neurobiology of dopamine receptor subtypes. Neurochem Int 1992 0.80
40 Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin. Neuropharmacology 1997 0.78
41 Biochemical and behavioral evidence for muscarinic autoreceptors in the CNS. Brain Res 1990 0.78
42 D2L, D2S, and D3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms. Synapse 1996 0.78
43 Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci 1992 0.77
44 Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor. Mol Pharmacol 1997 0.76
45 Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides. Behav Brain Res 1996 0.75
46 Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding site. Ann N Y Acad Sci 1998 0.75